News and Views
Nature Medicine 13, 129 - 131 (2007)
doi:10.1038/nm0207-129
Seeing what Alzheimer saw
Mony J de Leon1, Lisa Mosconi1 & Jean Logan1
- M.J. de Leon is at the Center for Brain Health at the New York University School of Medicine, 560 First Avenue, New York, New York 10016, USA, Nathan Kline Institute, Orangeburg, New York 10962, USA. e-mail: mony.deleon@med.nyu.edu
- L. Mosconi is at the Center for Brain Health at the New York University School of Medicine, 560 First Avenue, New York, New York 10016, USA.
- J. Logan is at the Brookhaven National Lab, Upton, New York 11973 USA.
Abstract
The ability to visualize brain pathology in living individuals with Alzheimer disease could change how the disease is diagnosed and drugs to treat it tested. A recently developed positron emission tomography tracer helps to image fibrillar amyloid-
and neurofibrillary tangles and brings us closer to this goal.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Seeing what Alzheimer sawNature Medicine News and Views (01 Feb 2007)
Pinpointing plaques with PIBNature Medicine News and Views (01 Jul 2006)
See all 12 matches for News And ViewsRESEARCH
Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-BJournal of Cerebral Blood Flow & Metabolism Original Article
Mutant prion proteins in Gerstmann-Str???ussler-Scheinker disease with neurofibrillary tanglesNature Genetics Article (01 Apr 1992)
See all 27 matches for Research
